Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Chen Lin: Gold, Silver, Critical Minerals — Where I’m Investing in 2025 March 12, 2025 Condor Energies Secures Second Critical Minerals Mining License in Kazakhstan March 12, 2025 Willem Middelkoop: Gold to Benefit as Chaos Rises, Silver’s Path to US$100 March 12, 2025